Characterization of Extramedullary Disease in B-ALL and Response to CAR T-cell Therapy.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021006035
Abstract: Chimeric antigen receptor (CAR) T-cells effectively eradicate medullary B-cell acute lymphoblastic leukemia (B-ALL) and can traffic to and clear central nervous system (CNS) involvement. CAR T-cell activity in non¬contral nervous system (CNS) extramedullary disease (EMD)… read more here.
Keywords: response; cns emd; car; non cns ... See more keywords